Related Experiment Videos

Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients

Ryosuke Nishiura1, Shouichi Fujimoto, Yuji Sato

  • 1Division of Circulatory and Body Fluid Regulation, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

American Journal of Nephrology
|September 20, 2008
PubMed

Insights

Elevated osteoprotegerin (OPG) levels in new hemodialysis (HD) patients correlate with increased cardiovascular events and mortality. This finding suggests OPG may serve as a predictive biomarker for cardiovascular risk in HD populations.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarkers

Background:

  • Patients undergoing hemodialysis (HD) face high risks of cardiovascular events linked to vascular calcification.
  • Osteoprotegerin (OPG), a known inhibitor of vascular calcification, is investigated for its role in these events.

Purpose of the Study:

  • To examine the association between serum OPG levels and the incidence of cardiovascular events and mortality in incident HD patients.

Main Methods:

  • A prospective cohort study was conducted with new HD patients from June 2000 to May 2006.
  • Serum OPG levels were measured and correlated with cardiovascular morbidity and mortality outcomes over a follow-up period.

Main Results:

  • The study followed 99 new HD patients for an average of 41.5 months.
  • Higher serum OPG levels were associated with a greater prevalence of cardiovascular morbidity and mortality.
  • Cox analysis indicated that high OPG levels predicted new cardiovascular events (HR 2.88, p=0.033) and were linked to older age, male gender, and aortic calcification.

Conclusions:

  • Elevated serum OPG levels in patients initiating hemodialysis may serve as a predictive marker for future cardiovascular events.
  • OPG's role in vascular calcification highlights its potential as a therapeutic target in HD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...